Physician profile
William Mack Malarkey
NPI 1689203267
$2,249.40
in general payments reported to CMS, 2019-2025
10 companies · $598 in 2025
The $598 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $386 · 2023: $629 · 2024: $636 · 2025: $598.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,766 · Travel and Lodging: $64.68 · Education: $32.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,766.43 |
| Travel and Lodging | $64.68 |
| Education | $32.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,399.78 | 2022-2025 | Gamma, Mako, Axsos |
| US Implant Solutions, LLC | $138.04 | 2025 | |
| Novus Surgical Consultants | $134.12 | 2023-2024 | |
| Medtronic, INC. | $125.98 | 2022 | |
| Si-Bone, INC. | $119.22 | 2023-2024 | |
| United Orthopedics LLC | $110.38 | 2025 | |
| Novus Surgical Solutions LLC | $102.61 | 2022 | |
| Orthalign INC | $53.17 | 2025 | Orthalign Plus |
| Arthrex, INC. | $48.25 | 2025 | |
| My01 INC. | $17.85 | 2025 | My01 Continuous Compartmental Pressure Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Malarkey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.